πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 429 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7261900

Recombinant modified Bacillus anthracis protective antigen for use in vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Aug 28 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 23 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7253147

Modified serum albumin with reduced affinity for nickel and copper

New Century Pharmaceuticals, Inc. Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7247708

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223388

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7220837

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7150869

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Tue Dec 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7119066

Modified ciliary neurotrophic factor (CNTF)

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7109303

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Tue Sep 19 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7074410

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 11 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 06 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7070959

Modified chimeric polypeptides with improved pharmacokinetic properties

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7067122

Modified live Edwardsiella tarda vaccine for aquatic animals

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 27 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7049116

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Tue May 23 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7041503

Modified myelin basic protein molecules

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 09 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 7029899

Selective toxicity of amino-terminal modified rnase a superfamily polypeptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 18 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6991793

Method of protecting fish against columnaris disease with modified live Flavobacterium col

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 31 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6890518

Compositions of chemically modified insulin

Nektar Therapeutics Β· Granted Tue May 10 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6884788

Thiol-modified hyaluronan

ANIKA THERAPEUTICS, INC. Β· Granted Tue Apr 26 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6881412

Modified live Flavobacterium columnare against columnaris disease in fish

The United States of America, as represented by the Secretary of the Agriculture Β· Granted Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6867289

Thio-modified aptamer synthetic methods and compositions

The Board of Regents of the University of Texas System Β· Granted Tue Mar 15 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6838076

Pulmonary administration of chemically modified insulin

Nektar Therapeutics Β· Granted Tue Jan 04 2005 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6787636

Modified serum albumin with reduced affinity for nickel and copper

New Century Pharmaceuticals, Inc. Β· Granted Tue Sep 07 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6762286

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota Β· Granted Tue Jul 13 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6747003

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota Β· Granted Tue Jun 08 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6692910

Inhibition of a target messenger RNA with a modified U1 small nuclear RNA

UNIVERSITY OF CONNECTICUT Β· Granted Tue Feb 17 2004 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired